Table 1. Key findings and future implications of the new HCV E2 envelope glycoprotein core structure described by Kong et al.8.
Experiment objective | Tools | Technique employed | Main results | Functional relevance Future implications |
---|---|---|---|---|
Structural characterization of E2 | E2c AR3C FAb | X-Ray crystallography | General globular shape despite irregular secondary structure, Central β sandwich bordered by two layers (front and back) comprising loops, short helices and β sheets | Understanding of : HCV morphology HCV/CD81 interactions HCV fusion process |
E2ΔTM AR3C FAb | Negative-stain EM | Confirmation of E2 globular structure, Remapping of regions absent in the E2c: N-terminal region next to the β sandwich Region 454-491 at the opposite face of the β sandwich C-terminal region behind back layer | HCV/host factors interaction research, Entry inhibitor development, Immunopreventive strategies, Vaccine design | |
Determination of CD81 receptor binding site | E1E2 heterodimer | Site-directed mutagenesis ELISA | Interaction of CD81 with residues of the front layer and the CD81 binding loop of E2 | |
d E2ΔTM Dimer of CD81 LEL AR2A FAb | Negative-stain EM | A dimer of CD81 and AR3C interacts with the same site on E2 |
E2c: aa 412-645, truncations at N- and C- termini, aa 460-485 substituted by a linker, removal of N448 and N576 E2ΔTM: aa 384-717; d E2ΔTM: Deglycosylated E2ΔTM; LEL: large external loop; EM: electron microscopy; ELISA: enzyme-linked immunosorbent assay